Reynolds L

Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Aucklandhttps://ror.org/03b94tp07, Grafton, Auckland, New Zealand.

10 papers · ORCID

ArticlePsychedelics

Exploring meaning in culture: Insights from meaning-centered psychotherapy in Aotearoa, New Zealand.

Clayden C, Wells A, Applebaum AJ +1

Europe PMC2026
ArticleLSD

It's all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial.

Cottam F, Wells A, Clayden C +1

Europe PMC2026
ArticleLSD

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +11

Europe PMC2026
ArticleLSD

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.

Joy Donegan C, Daldegan-Bueno D, Sumner RL +7

Europe PMC2025
ArticleLSD

LSD microdosing in major depressive disorder: results from an open-label trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +12

Europe PMC2026
ArticleLSD

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Donegan CJ, Daldegan-Bueno D, Noorani T +9

Europe PMC2025
ArticleMDMA

Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.

Bhagavan C, Glue P, Evans W +8

Europe PMC2024
ArticleLSD

PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.

Wells A, Muthukumaraswamy APS, Morunga E +10

Europe PMC2024
ArticleLSD

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15

Europe PMC2023
ArticleLSD

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Murphy RJ, Sumner RL, Evans W +8

Europe PMC2021